12628389_10153836389032145_2783262100588680571_o copy

Moustafa Khedr

Vice President/ Secretary

Moustafa is a Stem Cells and Developmental Biology PhD candidate at University College London (UCL) where he is working on developing a disease modelling platform for Duchenne Muscular Dystrophy (DMD), employing the latest stem cells, gene editing and tissue engineering technologies. Through his project, Moustafa was exposed to the process of translation of medical research from bed to bedside; and having to interact with various stakeholders, he quickly realised the urgent need to provide support for early-career researchers in their translational journey.

Moustafa’s interest in clinically translatable biological therapies,  and commercialisation of biomedical research led him to participating in the founding of Apollo London. In his spare time, Moustafa enjoys traveling, hiking, and working on architecture and product design projects.

Version 2

Grace Gong

Communications Officer

Grace is a postdoc at the UCL Cancer Institute working on anticancer drug discovery projects in collaboration with Pharma. Her main focus is on designing and characterising modulators of kinases as anticancer therapies, using a combination of molecular modelling, medicinal chemistry, structural biology, biochemistry and cell biology. These multi-disciplinary drug discovery projects allow her to work with scientists from a broad range of backgrounds, and expose her to various sections of the translational medicine pipeline.

Outside of science, Grace is a pianist, singer and song-writer. She enjoys orchestral concerts and musicals, and often use music to relax and stimulate new ideas.


Thomas Benoist

Operations Manager

Thomas is a French 1st year PhD student at the UCL Institute of Child Health. He initially studied a Master of Pharmacy at UCL, and qualified as a pharmacist. However, his goal always has been to pursue scientific research. His PhD is in Regenerative Medicine and Tissue Engineering. Its objective is improving current artificial organ production technology, focusing on tissue vascularization. The final goal is to find a solution to organ transplant shortages with increased availability and no associated graft rejections.
His interests in translational medicine are mainly around the field of Biotechnology and finds it fascinating to be able to take advantage of the wonderful capabilities of the living to develop new medical technologies.
In his spare time, he enjoys discovering more about my scientific interests, listening to and playing music (he’s a singer and guitarist), going for a run or walk and meeting up with friends.
Profile picture 7_Nazia Mehrban

Nazia Mehrban

Vice President/ Events Coordinator

Nazia is a tissue engineer working closely with surgeons in the repair and regeneration of several different types of tissues, such as neural tissue, skin and adipose tissue. She completed her PhD on engineering ligaments from University of Birmingham before moving to University of Bristol to learn more about protein design and the development of novel hydrogels for cell culture. Nazia is a Post-doctoral Research Fellow at UCL where she is developing novel, implantable materials towards tissue engineering; either as cell-populated scaffolds or towards biocompatible medical devices. Her current role allows her to work with engineers, biologists, chemists and even roboticists in exploring the diversity of research in translational medicine from bench to bedside.

In her spare time Nazia enjoys travelling and hiking and can often be found in the countryside (national or international) trying to combine the two. She also loves spending time with her family and friends, especially as it almost always involves good food!


Stephen Patrick


Stephen is based in the Centre for Advanced Biomedical Imaging (CABI) at UCL, where he develops and applies medical imaging techniques for non-invasively tracking transplanted cell therapies, bio-materials, and nanoparticles. Whether this involves labelling with radiotracers for nuclear imaging, or using contrast agents for MRI, the aim is to provide a better understanding of the behaviour of new therapies within the body, and to accelerate their translation.

Before joining UCL Stephen obtained a BSc in Cell Biology from the University of Durham, and a PhD from the University of Cambridge, where he developed new methods to image gene expression in vivo with Magnetic Resonance Imaging (MRI) and other imaging techniques. During his free time Stephen enjoys cooking, reading, and taking life easy.